A new variation of a therapy used to treat X-linked severe combined immunodeficiency syndrome uses a genetically engineered virus to help the body create disease-fighting T-cells. David A. Williams, Leland Fikes Professor of Pediatrics at Boston Children’s Hospital, coauthored the study.